What does PHARMA CHEMICALS do?

PHARMA CHEMICALS is filed with the CBE under the catch-all “Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten”, a code that says little about what the company actually does. Public Limited, started on 13 September 2016, 1 establishment.

What is the address of PHARMA CHEMICALS?

The registered office of PHARMA CHEMICALS is located at Parc Industriel(W-B) 19, 1440 Braine-le-Château.

Is PHARMA CHEMICALS still active?

Yes. According to the CBE (29 October 2026) PHARMA CHEMICALS is active, legal situation “Normale toestand”, started on 13 September 2016.

Is PHARMA CHEMICALS registered on Peppol?

Yes, PHARMA CHEMICALS is registered on the Peppol network with ID 0208:0662547315.

What is the enterprise number of PHARMA CHEMICALS?

The enterprise number of PHARMA CHEMICALS is BE0662547315.

When was PHARMA CHEMICALS founded?

PHARMA CHEMICALS was founded on 13 September 2016.

Who are the directors of PHARMA CHEMICALS?

According to the 2025 annual accounts, the directors of PHARMA CHEMICALS are: PROCURAM BV.

Is PHARMA CHEMICALS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 September 2016; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMA CHEMICALS make in 2025?

PHARMA CHEMICALS posted a profit after taxes of € 350,286 in financial year 2025.

What is the revenue of PHARMA CHEMICALS?

As a small company, PHARMA CHEMICALS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 2,169,641.

How much does an employee at PHARMA CHEMICALS earn?

The average wage cost per full-time employee at PHARMA CHEMICALS was € 53,700 in 2025: staff costs of € 1.2 million for 22.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMA CHEMICALS have?

According to the 2025 annual accounts, PHARMA CHEMICALS has 22.5 full-time equivalents (FTE).

PHARMA CHEMICALS (Public Limited) - Braine-le-Château

Dossier PHARMA CHEMICALS, printed on 29 October 2026 from databakkes.be/en/0662547315/pharma-chemicals. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 52 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMA CHEMICALS from Braine-le-Château, company number BE0662547315, closed financial year 2025 with a result of € 350,286 after tax. For that financial year PHARMA CHEMICALS recorded a gross margin of € 2.2 million and equity of € 1 million. Compared with financial year 2024, the result moved from € 693,747 to € 350,286. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 1 million

▲ 51% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 350,286

▼ 50% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 403,879

▼ 28% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 233,477.

People and assets in 2025

Full-time equivalents

22.5

▲ 1.5 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 1.2 million

▲ 10% vs 2024

€ 53,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 37,921

▼ 9% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.3 million

▼ 3% vs 2024

€ 128,291 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 534,014

▼ 22% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 349,294

▲ 62% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 937,455 Gross margin 2022: € 937,455 First fiscal year in the series	€ 1,294,364 Gross margin 2023: € 1,294,364 ▲ 38% vs 2022 (€ 937,455) Favourable step	€ 2,094,630 Gross margin 2024: € 2,094,630 ▲ 62% vs 2023 (€ 1,294,364) Favourable step	€ 2,169,641 Gross margin 2025: € 2,169,641 ▲ 4% vs 2024 (€ 2,094,630) Favourable step	▲ 4%
Profit after taxes	€ -456,900 Profit after taxes 2022: € -456,900 First fiscal year in the series	€ 114,408 Profit after taxes 2023: € 114,408 ▲ € 571,308 vs 2022 (€ -456,900) Favourable step	€ 693,747 Profit after taxes 2024: € 693,747 ▲ € 579,339 vs 2023 (€ 114,408) Favourable step	€ 350,286 Profit after taxes 2025: € 350,286 ▼ 50% vs 2024 (€ 693,747) Unfavourable step	▼ 50%
Equity	€ -99,801 Equity 2022: € -99,801 First fiscal year in the series	€ -5,406 Equity 2023: € -5,406 ▲ € 94,395 vs 2022 (€ -99,801) Favourable step	€ 688,341 Equity 2024: € 688,341 ▲ € 693,747 vs 2023 (€ -5,406) Favourable step	€ 1,038,627 Equity 2025: € 1,038,627 ▲ 51% vs 2024 (€ 688,341) Favourable step	▲ 51%
Total debts	€ 2,447,486 Total debts 2022: € 2,447,486 First fiscal year in the series	€ 2,479,693 Total debts 2023: € 2,479,693 ▲ 1% vs 2022 (€ 2,447,486) Unfavourable step	€ 2,264,598 Total debts 2024: € 2,264,598 ▼ 9% vs 2023 (€ 2,479,693) Favourable step	€ 2,207,326 Total debts 2025: € 2,207,326 ▼ 3% vs 2024 (€ 2,264,598) Favourable step	▼ 3%
Cash	€ 368,838 Cash 2022: € 368,838 First fiscal year in the series	€ 564,098 Cash 2023: € 564,098 ▲ 53% vs 2022 (€ 368,838) Favourable step	€ 558,141 Cash 2024: € 558,141 ▼ 1% vs 2023 (€ 564,098) Unfavourable step	€ 403,879 Cash 2025: € 403,879 ▼ 28% vs 2024 (€ 558,141) Unfavourable step	▼ 28%
Retained profit	€ -924,964 Retained profit 2022: € -924,964 First fiscal year in the series	€ -810,556 Retained profit 2023: € -810,556 ▲ € 114,408 vs 2022 (€ -924,964) Favourable step	€ -116,809 Retained profit 2024: € -116,809 ▲ € 693,747 vs 2023 (€ -810,556) Favourable step	€ 233,477 Retained profit 2025: € 233,477 ▲ € 350,286 vs 2024 (€ -116,809) Favourable step	▲ € 350,286
Bank debt	€ 1,484,996 Bank debt 2022: € 1,484,996 First fiscal year in the series	€ 1,410,946 Bank debt 2023: € 1,410,946 ▼ 5% vs 2022 (€ 1,484,996) Favourable step	€ 1,367,457 Bank debt 2024: € 1,367,457 ▼ 3% vs 2023 (€ 1,410,946) Favourable step	€ 1,324,018 Bank debt 2025: € 1,324,018 ▼ 3% vs 2024 (€ 1,367,457) Favourable step	▼ 3%
Balance sheet total	€ 2,347,685 Balance sheet total 2022: € 2,347,685 First fiscal year in the series	€ 2,474,287 Balance sheet total 2023: € 2,474,287 ▲ 5% vs 2022 (€ 2,347,685) Unchanged	€ 2,952,939 Balance sheet total 2024: € 2,952,939 ▲ 19% vs 2023 (€ 2,474,287) Unchanged	€ 3,245,953 Balance sheet total 2025: € 3,245,953 ▲ 10% vs 2024 (€ 2,952,939) Unchanged	▲ 10%
Employees (FTE)	16.9 Employees (FTE) 2022: 16.9 First fiscal year in the series	18.5 Employees (FTE) 2023: 18.5 ▲ 1.6 vs 2022 (16.9) Unchanged	21 Employees (FTE) 2024: 21 ▲ 2.5 vs 2023 (18.5) Unchanged	22.5 Employees (FTE) 2025: 22.5 ▲ 1.5 vs 2024 (21) Unchanged	▲ 1.5

Key figures of PHARMA CHEMICALS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMA CHEMICALS?

What happened at PHARMA CHEMICALS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 350,286 (▼ 50% vs 2024). filed late Source: NBB ↗
Sep 13, 2016 New establishment in Braine-le-Château. KBO
Sep 13, 2016 Start of the company according to the CBE. KBO

In short

From € 456,900 loss in 2022 to € 350,286 profit in 2025.

Paid € 198,703 in corporate taxes since 2022.

Best year ever: 2024, with € 693,747 profit.

On average € 96,400 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Pharmentum 100%

The stake of Pharmentum comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMA CHEMICALS

Behind PHARMA CHEMICALS is PROCURAM BV. The shares are held by Pharmentum (100%).

Directors

According to the 2025 annual accounts

PROCURAM BV

Director

Also active at: PANNOC CHEMIE, Pharmentum, Pharma Chemicals France

Shareholders

Pharmentum

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Parc Industriel(W-B) 19

1440 Braine-le-Château

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Pharma Chemicals France same network

€ -110,505 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0662.547.315

VAT number

BE 0662.547.315

Registered office

Parc Industriel(W-B) 19, 1440 Braine-le-Château

Names & denominations

PHARMA CHEMICALS

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

13 September 2016

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg

Vervaardiging van overige farmaceutische producten

Overige gespecialiseerde wetenschappelijke en technische activiteiten

Activiteiten van verpakkingsbedrijven

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMA CHEMICALS

Warning lights

Financials

What happened to PHARMA CHEMICALS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions